Barometer Capital Management Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 38.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,130 shares of the healthcare conglomerate’s stock after selling 58,770 shares during the period. UnitedHealth Group accounts for about 1.8% of Barometer Capital Management Inc.’s portfolio, making the stock its 18th largest position. Barometer Capital Management Inc.’s holdings in UnitedHealth Group were worth $17,454,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC increased its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the last quarter. Cribstone Capital Management LLC increased its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the last quarter. Kings Point Capital Management increased its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the last quarter. Founders Capital Management acquired a new position in UnitedHealth Group during the first quarter worth approximately $135,000. Finally, Parkside Financial Bank & Trust increased its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the last quarter. 86.21% of the stock is owned by institutional investors.

UnitedHealth Group Incorporated (NYSE UNH) traded down 0.18% during midday trading on Thursday, reaching $193.42. 663,426 shares of the company’s stock traded hands. The stock has a 50-day moving average of $190.13 and a 200 day moving average of $175.54. The company has a market cap of $187.01 billion, a P/E ratio of 23.24 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $196.04.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.96 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s payout ratio is 35.13%.

WARNING: This report was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://theolympiareport.com/2017/08/17/barometer-capital-management-inc-has-17-45-million-stake-in-unitedhealth-group-incorporated-unh.html.

UNH has been the subject of a number of analyst reports. UBS AG reaffirmed a “buy” rating and set a $194.00 price objective (up from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Jefferies Group LLC reaffirmed a “buy” rating and set a $192.00 price objective (up from $186.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Deutsche Bank AG reaffirmed a “buy” rating and set a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective for the company in a report on Monday, May 15th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $185.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $202.20.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the transaction, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,540 shares of company stock valued at $2,873,320. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.